Back

Whole-Slide ECM Imaging Reveals Dense Fibrous Matrix as a High-Risk Factor for Recurrence in Stage II Colon Cancer

Ravensbergen, C.; Colaco, V.; Putter, H.; Crobach, S.; Boonstra, J.; Lindeman, J.; Tollenaar, R.; Mesker, W.

2024-11-15 cancer biology
10.1101/2024.11.14.622985 bioRxiv
Show abstract

IntroductionThe extracellular matrix (ECM) supports tumor progression by influencing tumor cell migration and invasion. This study examines the link between peritumoral ECM morphology and five-year recurrence risk in TNM Stage II colon cancer, using quantitative whole-slide ECM imaging. We hypothesize that loose ECM regions are associated with increased recurrence risk due to enhanced tumor budding (TB) or poorly differentiated clusters (PDC). MethodsIn a case-control study of 100 TNM Stage II colon cancer patients (25 with recurrence and 75 controls matched by lymph node sampling and tumor extent), Picrosirius red-stained sections were imaged to quantify ten ECM parameters across 798 regions of interest (ROIs). Conditional logistic regression assessed associations between ECM morphologies, TB, PDCs, and recurrence. ResultsUnsupervised clustering identified three ECM morphologies: dense fibrous, loose sparse, and complex tortuous. Dense fibrous ECM correlated strongly with recurrence (aOR 9.43, 95% CI 3.29-29.30, p < 0.001), while loose sparse and complex tortuous ECMs were associated with reduced recurrence risk (aOR 0.33, 95% CI 0.11-0.91, p = 0.040, and aOR 0.14, 95% CI 0.02-0.53, p = 0.012, respectively). TB was highest in loose sparse ECM (mean 9.3), and PDCs were highest in dense fibrous ECM (mean 5.5). DiscussionOur findings suggest that ECM morphology, particularly dense fibrous ECM, predicts recurrence in Stage II colon cancer, highlighting ECM profiling as a promising tool for patient stratification beyond traditional staging.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
The Journal of Pathology
26 papers in training set
Top 0.1%
13.6%
2
Cancers
213 papers in training set
Top 0.5%
8.2%
3
npj Precision Oncology
53 papers in training set
Top 0.2%
5.8%
4
Scientific Reports
3612 papers in training set
Top 14%
5.8%
5
PLOS ONE
5266 papers in training set
Top 32%
4.5%
6
BMC Cancer
67 papers in training set
Top 0.6%
3.2%
7
Cancer Research
130 papers in training set
Top 1%
2.9%
8
The American Journal of Pathology
32 papers in training set
Top 0.2%
2.9%
9
Biomaterials
84 papers in training set
Top 0.6%
2.7%
10
Matrix Biology Plus
10 papers in training set
Top 0.1%
2.7%
50% of probability mass above
11
Breast Cancer Research
36 papers in training set
Top 0.3%
2.2%
12
eLife
5828 papers in training set
Top 46%
2.0%
13
Molecular Cancer Research
49 papers in training set
Top 0.6%
2.0%
14
Laboratory Investigation
13 papers in training set
Top 0.1%
1.8%
15
International Journal of Cancer
49 papers in training set
Top 0.6%
1.8%
16
Journal of Translational Medicine
57 papers in training set
Top 0.9%
1.6%
17
Frontiers in Oncology
103 papers in training set
Top 2%
1.6%
18
Nature Communications
5641 papers in training set
Top 48%
1.4%
19
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 1%
1.4%
20
Theranostics
37 papers in training set
Top 0.6%
1.2%
21
Clinical Cancer Research
64 papers in training set
Top 1%
1.2%
22
Modern Pathology
22 papers in training set
Top 0.3%
1.2%
23
OncoImmunology
24 papers in training set
Top 0.5%
1.2%
24
Journal of Experimental & Clinical Cancer Research
25 papers in training set
Top 0.4%
1.2%
25
Acta Neuropathologica Communications
89 papers in training set
Top 1%
1.2%
26
Neoplasia
23 papers in training set
Top 0.5%
1.2%
27
Genome Medicine
183 papers in training set
Top 4%
1.1%
28
Translational Oncology
21 papers in training set
Top 0.7%
1.0%
29
Communications Biology
993 papers in training set
Top 28%
0.9%
30
Genome Biology
637 papers in training set
Top 9%
0.6%